دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش:
نویسندگان: Earl Usdin (Eds.)
سری:
ISBN (شابک) : 9781483283630
ناشر:
سال نشر: 1979
تعداد صفحات: 1954
زبان: English
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود)
حجم فایل: 122 مگابایت
در صورت تبدیل فایل کتاب Catecholamines: Basic and Clinical Frontiers. Proceedings of the Fourth International Catecholamine Symposium, Pacific Grove, California, September 17-22, 1978 به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب کاتکولامین ها: مرزهای اساسی و بالینی. مجموعه مقالات چهارمین سمپوزیوم بین المللی کاتکول آمین، پاسیفیک گرو، کالیفرنیا، 17-22 سپتامبر 1978 نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
Catecholamines: Basic and Clinical Frontiers مجموعه مقالاتی است که مشکلات بالینی مربوط به این سری از ترکیبات شامل دوپامین، اپی نفرین و نوراپی نفرین را مورد بحث قرار می دهد. یک مقاله نقش آمین های بیوژنیک را در چندین اختلال روانی، مانند زوال عقل پیر، اسکیزوفرنی، الکلیسم مزمن، و اختلالات عاطفی مورد بحث قرار می دهد. مقاله دیگری توضیح میدهد که در مطالعات روی موشها، تعداد نورونهای خاص انتقالدهنده عصبی تحت کنترل ژنتیکی است و میتواند عامل تعیینکننده مهمی در تغییرات وابسته به گونهها در شیمی مغز، سازمان هستهای، پاسخهای دارویی و رفتار خود به خودی باشد. یک مقاله بررسی میکند که آیا پروستاگلاندینها میتوانند مستقیماً آزادسازی یا بازجذب کاتکول آمینها را در سیستم عصبی مرکزی و همچنین اثر آنها بر روی متابولیتهای مختلف دوپامین و نوراپی نفرین در پرفیوژن مغز را تغییر دهند. اثرات چندین دارو بر جنگ ناشی از شوک در موشها هیچ جنبه قابلتوجهی با آمفتامین، آپومورفین، فنوکسی بنزامین یا فنتولامین نشان نمیدهد. استفاده از کلونیدین و پروپرانولول مهار قابل توجهی از مبارزه را نشان می دهد، در حالی که دوزهای پایین پیپروکسان افزایش قابل توجهی در رفتار مبارزه نشان می دهد. این مجموعه می تواند برای فارماکولوژیست ها، بیوشیمی ها، میکروبیولوژیست ها، محققان سلولی و دانشگاهیان درگیر در مطالعه فیزیولوژی یا غدد عصبی مفید باشد.
Catecholamines: Basic and Clinical Frontiers is a collection of papers that discusses clinical problems related to this series of compounds which includes dopamine, epinephrine, and norepinephrine. One paper discusses the role of biogenic amines in several mental disorders, such as senile dementia, schizophrenia, chronic alcoholism, and affective disorders. Another paper describes that in studies of mice, the number of neurotransmitter-specific neurons is under a genetic control and can be a significant determinant of species-dependent variation in brain chemistry, nuclear organization, drug responses, and spontaneous behavior. One paper investigates if prostaglandins can directly alter the release or reuptake of catecholamines in the central nervous system, as well as their action upon the disposition of different metabolites of dopamine and norepinephrine in brain perfusate. The effects of several drugs on shock elicited fighting in rats show no significant aspects with amphetamine, apomorphine, phenoxybenzamine or phentolamine. The use of clonidine and propranolol shows a significant inhibition of fighting, while low doses of piperoxane exhibits a marked increase in fighting behavior. The collection can prove beneficial for pharmacologists, biochemists, micro-biologists, cellular researchers, and academicians involved in the study of physiology or neuroendocrinology.
Content:
Pergamon Titles of Related Interest, Page ii
Front Matter, Page iii
Copyright, Page iv
INTRODUCTION, Pages xxi-xxviii, Earl Usdin, Irwin J. Kopin, Jack D. Barchas
ACTIVE PARTICIPANTS, Pages xxviii-xlvii
ABBREVIATIONS, Pages xlix-lvi
CATECHOLAMINE RESEARCH: A PARADIGM FOR THE RELATIONSHIP BETWEEN BASIC INVESTIGATIONS AND CLINICAL APPLICATIONS IN PSYCHIATRY, Pages 1-3, Gerald L. Klerman
THE IMPACT OF CATECHOLAMINE RESEARCH ON MEDICAL SCIENCE AND PRACTICE, Pages 4-19, Arvid Carlsson
A GENETIC CONTROL OF THE NUMBER OF CENTRAL DOPAMINE NEURONS IN RELATIONSHIP TO BRAIN ORGANIZATION, DRUG RESPONSES, AND BEHAVIOR, Pages 23-33, Donald J. Reis, Harriet Baker, J. Stephen Fink, Tong H. Joh
REGULATION OF TYROSINE HYDROXYLASE, Pages 34-39, Toshiharu Nagatsu
ACTIVATION AND PHOSPHORYLATION OF TYROSINE HYDROXYLASE BY cAMP, Pages 40-42, Jack C. Waymire, John W. Haycock, John A. Meligeni, Mike D. Browning
DIRECT PHOSPHORYLATION OF TYROSINE HYDROXYLASE BY CYCLIC AMP-DEPENDENT PROTEIN KINASE: MECHANISM OF ENZYME ACTIVATION, Pages 43-45, Tong H. Joh, Dong H. Park, Donald J. Reis
TYROSINE HYDROXYLASE FROM BRAIN: PHOSPHORYLATION OF THE ENZYME BY CYCLIC AMP-DEPENDENT PROTEIN KINASE, Pages 46-48, Joachim D. Raese, Arthur M. Edelman, Mitchell A. Lazar, Jack D. Barchas
THE ACTIVATION OF TYROSINE HYDROXYLASE IN NORADRENERGIC NEURONS DURING ACUTE NERVE STIMULATION, Pages 49-51, N. Weiner, M. Posiviata, E. Dreyer, F.-L. Lee
SEROTONINERGIC CONTROL OF TYROSINE HYDROXYLASE (TH) AND DOPAMINE-β-HYDROXYLASE (DBH) IN THE RAT LOCUS COERULEUS (LC), Pages 52-54, J.F. PUJOL, A. McRAE-DEGUEURCE, F. CRESPI, P. KEANE, B. RENAUD, L. LEGER, M. BUDA
THE PHARMACOLOGY OF STRIATAL PTERINS AND THE REGULATION OF DOPAMINERGIC FUNCTION, Pages 55-57, Wilson P. Bullard, Joseph B. Yellin, Arnold J. Mandell
THE ROLE OF NEURAL ACTIVITY IN THE REGULATION OF THE BIOCHEMISTRY OF NEURONS AND THEIR TARGET CELLS, Pages 58-60, Richard E. Zigmond, Alcmène Chalazonitis, Chauncey W. Bowers
ROLE OF PROTEIN KINASE TRANSLOCATION IN THE INDUCTION OF TYROSINE-3-MONOOXYGENASE (TH) IN ADRENAL CHROMAFFIN CELL CULTURES, Pages 61-63, K. Kumakura, A. Guidotti, E. Costa
RELATION BETWEEN BRAIN TYROSINE AND CATECHOLAMINE SYNTHESIS, Pages 64-66, R.J. Wurtman, M.C. Scally, C.J. Gibson, F. Hefti
EFFECT OF BIVALENT CATIONS ON THE UPTAKE OF L-TYROSINE BY SYNAPTOSOMES, Pages 67-69, J. Bruinvels, P. Moleman
ISOLATED BOVINE ADRENAL MEDULLARY CELLS: STUDIES ON REGULATION OF CATECHOLAMINE SYNTHESIS AND RELEASE, Pages 70-72, Motoo OKA, Minoru ISOSAKI, Nobuyuki YANAGIHARA
CENTRAL NEUROGENIC REGULATION OF ADRENAL TYROSINE HYDROXYLASE, Pages 73-75, S. Gauthier, J.-P. Gagner, T.L. Sourkes
RAT PHEOCHROMOCYTOMA TYROSINE HYDROXYLASE AND DOPAMINE β HYDROXYLASE: PURIFICATION AND CHARACTERIZATION, Pages 76-78, K.A. Markey, J.C. Fong, M. Goldstein, L. Shenkman
AMPHETAMINE-INDUCED INHIBITION OF SYNAPTOSOMAL DOPAMINE SYNTHESIS ACTIVATION, Pages 79-81, Robert L. Patrick
THE INVOLVEMENT OF CALCIUM IN THE AMPHETAMINE-INDUCED STIMULATION OF DOPAMINE SYNTHESIS IN STRIATAL SLICES, Pages 82-84, Norman J. Uretsky, S. Robert Snodgrass
REGULATION OF DOPAMINE SYNTHESIS WITHIN STRIATAL SYNAPTOSOMES, Pages 85-87, Gregory Kapatos, Michael Zigmond
THE REGULATION OF TYROSINE 3-MONOOXYGENASE ACTIVITY IN PHEOCHROMOCYTOMA CELLS, Pages 88-90, Robert L. Perlman
Short- and Long-Term Control of Tyrosine Hydroxylase Activity in Nigrostriatal Dopamine Neurons: Multiple Neural Mechanisms, Pages 91-93, Karen Gale
TYROSINE HYDROXYLASE: A SUBSTRATE FOR CYCLIC AMP-DEPENDENT PROTEIN KINASE IN VITRO, Pages 94-96, P.R. Vulliet, T.A. Langan, N. Weiner
THE EFFECT OF CARBACHOL ON THE INDUCTION OF TYROSINE HYDROXYLASE ELICITED BY COMPOUNDS WHICH RAISE CYCLIC AMP LEVELS IN NEUROBLASTOMA CELLS, Pages 97-99, A.W. Tank, M. Posiviata, N. Weiner
SIMILARITIES BETWEEN THE IN VIVO ACTIVATION OF ADRENAL TYROSINE HYDROXYLASE AND THE IN VITRO ACTIVATION OF THE ENZYME BY AN ADENOSINE 3′,5′-MONOPHOSPHATE DEPENDENT PROTEIN PHOSPHORYLATING SYSTEM, Pages 100-102, J. Masserano, N. Weiner
MODULATION OF TYROSINE HYDROXYLASE ACTIVITY BY PHOSPHOLIPIDS: THE EFFECTS OF PHOSPHATIDYLINOSITOL, Pages 103-105, Tom Lloyd
THE ROLE OF CYCLIC NUCLEOTIDES IN THE IN VIVO SYNTHESIS OF CATECHOLAMINES IN RAT BRAIN, Pages 106-108, Wolfgang Kehr, Gerlinde Debus
SIGNIFICANCE OF TYROSINE HYDROXYLASE ACTIVATION IN THE REGULATION OF DOPAMINE SYNTHESIS, Pages 109-111, B. ZIVKOVIC
REGULATION OF HYPOTHALAMIC BETA-ADRENERGIC FUNCTION BY PHOSPHATIDYLSERINE, Pages 112-114, S. Teolato, G. Savoini, G. Toffano
EFFECT OF NERVE GROWTH FACTOR ON GENERAL GROWTH AND DIFFERENTIATION OF SYMPATHETIC NEURONS: INDUCTION OF ORNITHINE DECARBOXYLASE AND TYROSINE HYDROXYLASE AS RESPECTIVE EXAMPLES, Pages 115-117, Uwe Otten, Hiroshi Hatanaka, Hans Thoenen
TYROSINE HYDROXYLASE ACTIVITY IN THE MOUSE SUPERIOR CERVICAL GANGLION INFECTED WITH HERPES SIMPLEX VIRUS, Pages 118-120, Richard W. Price, Tong H. Joh, Donald J. Reis
RETINAL TYROSINE HYDROXYLASE: STIMULATION IN VIVO BY LIGHT AND IN VITRO BY cAMP-DEPENDENT PROTEIN PHOSPHORYLATION CONDITIONS, Pages 121-123, P.M. Iuvone, N.H. Neff
THE METABOLISM AND FUNCTION OF MONOAMINES IN IRON-DEFICIENT RATS, Pages 124-126, M.B.H. Youdim, A.R. Green
Round Table on: IS THERE DOPA DECARBOXYLASE IN HUMAN BRAIN?, Pages 127-131, W. Sacks, W.H. Vogel, T. Nagatsu, Kenneth G. Lloyd, M. Sandler
ENZYME-ACTIVATED IRREVERSIBLE INHIBITION OF AROMATIC L-AMINO ACID DECARBOXYLASE (AADC) BY α-DIFLUOROMETHYL DOPA (DFMD, RMI 71.801) AND α-MONOFLUOROMETHYL DOPA (MFMD, RMI 71.963), Pages 132-134, Michael G. Palfreyman, Michel J. Jung, Charles Danzin, Gilles Ribereau-Gayon, Philippe Bey, Monique Zraika, Albert Sjoerdsma
ISOLATION AND PRELIMINARY AMINO ACID ANALYSES OF DOPAMINE β-HYDROXYLASE (DβH) FROM PURIFIED LARGE DENSE CORED NORADRENERGIC VESICLES (LDV), Pages 135-137, Wen-Hsun Yang, Milton S. Gasparis, Richard L. Klein
REDUCED RATE OF SYNTHESIS OF DOPAMINE-β-HYDROXYLASE IN LOCUS COERULEUS DURING AXONAL REGENERATION, Pages 138-140, R.A. Ross, T.H. Joh, D.J. Reis
COMPARISONS OF ANTIGENICALLY PURE DOPAMINE β-HYDROXYLASE (DβH) FROM BOVINE LARGE DENSE CORED NORADRENERGIC VESICLES (LDV) AND ADRENOMEDULLARY CHROMAFFIN GRANULES (AMG), Pages 141-143, Richard L. Klein, Wen-Hsun Yang, Milton S. Gasparis
ISOTOPE EFFECTS IN THE HYDROXYLATION OF DOPAMINE BY DOPAMINE-ß-HYDROXYLASE (DBH), Pages 144-146, T. Kato, T. Nagatsu, Y. Hashimoto, H. Miyazaki, M. Levitt, J.M. Perel
HUMAN SERUM DOPAMINE-β-HYDROXYLASE BIOCHEMICAL GENETICS, Pages 147-149, Joel Dunnette, Richard Weinshilboum
THE ROLE OF DOPAMINE /DA/ IN NORADRENALINE /NA/ BIOSYNTHESIS IN HYPOTHALAMIC NEURONS, Pages 150-152, Zsuzsanna Huszti, Géza Szilágyi, Endre Kasztreiner
N,N-DIMETHYL-N′-1H-1,2,4-TRIAZOL-3-YL-THIOUREA, A POTENT DOPAMINE-β-HYDROXYLASE INHIBITOR, Pages 153-155, V. CLAASSEN, TH.A.C. BOSCHMAN, F.C. HILLEN, W.J. VAATSTRA
CATECHOLAMINE TURNOVER TIME IN SELECTED PARTS OF THE RAT BRAIN DURING HYPOBARIC HYPOXIA, Pages 156-158, M. Prioux-Guyonneau, E. Cretet, C. Jacquot, J.R. Rapin, Y. Cohen
PHENYLETHANOLAMINE-N-METHYLTRANSFERASE AND EPINEPHRINE IN THE BRAIN, Pages 159-161, M. Goldstein, A. Sauter, J.Y. Lew, Y Baba, J. Engel, K. Fuxe, T. Hokfelt
REGULATION OF PHENYLETHANOLAMINE N-METHYLTRANSFERASE SYNTHESIS AND DEGRADATION, Pages 162-167, Roland D. Ciaranello
REGULATION OF PHENYLETHANOLAMINE-N-METHYLTRANSFERASE IN CULTURED EXPLANTS OF RAT ADRENAL MEDULLA, Pages 168-170, W.J. Burke, J.W. Davis, D.J. Reis, T.H. Joh
ADRENALINE SYNTHESIZING ENZYME DISTRIBUTION IN HUMAN BRAIN, Pages 171-173, N. KOPP, L. DENOROY, B. RENAUD, J.F. PUJOL, N. GAY, M. TOMMASI
EP INEPHRINE FORMING ENZYME IN HUMAN BRAIN, Pages 174-176, Elizabeth Erdelyi, Roland D. Ciaranello, Jack D. Barchas
PHENYLETHANOLAMINE N-METHYLTRANSFERASE FROM BRAIN AND ADRENAL MEDULLA OF RAT, Pages 177-179, Peter H. Yu
THE EFFECTS OF HYPOPHYSECTOMY ON THE KINETICS AND REGULATION OF PNMT IN THE BRAIN AND ADRENAL GLANDS OF RATS, Pages 180-182, Willa Phyall, Walter Lovenberg
ROLE OF STRESS IN THE REGULATION OF CENTRAL EPINEPHRINE SYNTHESIS, Pages 183-185, B.B. Turner, R.J. Katz, B.J. Carroll
LOWERING OF BRAIN EPINEPHRINE BY INHIBITION OF NOREPINEPHRINE N-METHYLTRANSFERASE IN RATS, Pages 186-188, Ray W. Fuller, Kenneth W. Perry, Susan K. Hemrick, Bryan B. Molloy
SOME NEW INHIBITORS OF EPINEPHRINE BIOSYNTHESIS. IMPORTANCE OF THE AROMATIC RING IN ADRENERGIC AMINES. 4. (Ref. 1), Pages 189-191, Gary L. Grunewald, William C. Vincek, Dwight P. Davis, Ronald T. Borchardt
EXPRESSION OF CATECHOLAMINE-SYNTHESIZING ENZYMES IN HUMAN NEUROBLASTOMA LINES WITH UNIQUE CHROMOSOMAL ABNORMALITIES, Pages 192-194, June L. Biedler, Barbara A. Spengler, Robert A. Ross
ON THE ROLE OF HYDROXYLIC AND N-METHYL GROUPS IN THE INTERACTION OF PHENYLETHYLAMINES WITH MONOAMINE OXIDASE TYPES A AND B, Pages 195-197, E.A. Zeller, K.L. Arora
THE TOPOGRAPHY OF MITOCHONDRIAL MAOs, Pages 198-200, S. Weiss, R. McCauley
DOPAMINE OXIDATION AND ITS INHIBITION BY (−)-DEPRENYL IN HUMAN BRAIN AND TISSUES, Pages 201-203, Vivette Glover, J.D. Elsworth, M. Sandler
SUBSTRATE SPECIFICITY AND INHIBITOR CHARACTERISTICS OF BRAIN MONOAMINE OXIDASE AT THE MITOCHONDRIAL LEVEL, Pages 204-206, Frances M. Achee, Sabit Gabay
BENZYLAMINE OXIDASE IN HUMAN AND RAT TISSUES, Pages 207-209, Rachel Lewinsohn, Vivette Glover, K.-H. Böhm, M. Sandler
Catecholamine Metabolism and Drug Effects in Cultured Mammalian Cells: Analysis by HPLC, Pages 210-212, Peter A. Crooks, Xandra O. Breakefield, James K. Coward
CONJUGATES OF 3-METHOXY-4-HYDROXYPHENYLETHYLENE GLYCOL IN MAN, Pages 213-215, A R Boobis, S Murray, H Jones, J L Reid, D S Davies
CATECHOL-O-METHYLTRANSFERASE BIOCHEMICAL GENETICS, Pages 216-218, Richard Weinshilboum
IMMUNOCYTOCHEMICAL LOCALIZATION OF CATECHOL-O-METHYLTRANSFERASE IN CARDIOVASCULAR TISSUES, Pages 219-221, Michael C. Lowe, Cyrus R. Creveling
MOLECULAR ASPECTS OF MONOAMINE OXIDASE ACTIVE SITE, Pages 222-224, M.B.H. Youdim, J.I. Salach
EFFECT OF A CATECHOL-O-METHYL TRANSFERASE INHIBITOR, U-0521, WITH LEVODOPA ADMINISTRATION, Pages 225-227, Stanley Fahn, Richard Comi, Stuart R. Snider, A.L.N. Prasad
DENDRITIC RELEASE OF DOPAMINE: ITS ROLE IN THE CONTROL OF NIGROSTRIATAL DOPAMINERGIC NEURONES, Pages 231-239, Jacques Glowinski, André Chéramy
CURRENT ISSUES IN THE STUDY OF NOREPINEPHRINE SECRETION FROM NORADRENERGIC NERVES, Pages 240-243, Lennart Stjarne
THE MECHANISM OF NEURONAL RELEASE OF ADRENERGIC TRANSMITTERS BY LOW SODIUM AND HYPO-OSMOTIC SHOCK, Pages 244-246, E. Muscholl, H. Ritzel
SYNTHESIS AND RELEASE OF CYCLIC GMP BY NERVE ENDINGS IN THE RAT PINEAL GLAND AND NEUROHYPOPHYSIS, Pages 247-249, Martin Zatz, Robert F. O'Dea
ISOLATION AND CHARACTERIZATION OF THE METHYL ACCEPTOR PROTEIN FROM ADRENAL CHROMAFFIN GRANULES, Pages 250-252, Ronald T. Borchardt, Julie Olsen, Lee Eiden, Richard L. Schowen, Charles O. Rutledge
CHARACTERISTICS OF PRESYNAPTIC INHIBITION OF NOREPINEPHRINE RELEASE BY ADENOSINE AND RELATED ANALOGS, Pages 253-255, David M. Paton
ADENOSINE AS MODULATOR OF ADRENERGIC NEUROEFFECTOR TRANSMISSION, Pages 256-258, Per Hedqvist, Bertil B. Fredholm
IN VITRO STUDIES ON PRESYNAPTIC ALPHA-RECEPTOR MEDIATED MODULATION OF TRANSMITTER RELEASE FROM CENTRAL NORADRENERGIC NEURONS, Pages 259-261, Arie H. Mulder, Cees D.J. de Langen, Johan Wemer, Key Dismukes
VESICLE POPULATIONS AND EXOCYTOSIS IN NORADRENERGIC TERMINALS OF HUMAN VEINS, Pages 262-264, Åsa Thureson-Klein, Richard L. Klein, Lennart L. Stjärne
EFFECT OF DOPAMINE ON THE NERVE-STIMULATION MEDIATED RELEASE OF NOREPINEPHRINE (NE) AND DOPAMINE β-HYDROXYLASE (DBH) FROM THE ISOLATED PERFUSED CAT SPLEEN, Pages 265-267, W.R. Dixon, W. Mosimann, N. Weiner
ON THE MECHANISM OF NEURONAL EFFLUX OF AXOPLASMIC 3H-(−)NORADRENALINE, Pages 268-270, Karl-Heinz Graefe, Günter Fuchs
AN ADRENALINE-MEDIATED POSITIVE FEEDBACK LOOP IN SYMPATHETIC TRANSMISSION, Pages 271-273, Henryk Majewski, Marian McCulloch, Michael Rand, David Story
POSSIBLE INVOLVEMENT OF CYCLIC AMP IN FACILITATION OF NOREPINEPHRINE RELEASE MEDIATED BY PRESYNAPTIC BETA-ADRENOCEPTORS IN THE RAT PINEAL GLAND, Pages 274-276, M.L. Dubocovich, F. Pelayo, S.Z. Langer
THE MECHANISMS OF PGE, ALPHA ADRENERGIC AND BETA ADRENERGIC REGULATION OF CATECHOLAMINE RELEASE: EVIDENCE FOR DIFFERENT MODES OF ACTION, Pages 277-279, YEHUDA GUTMAN
REGULATION OF CATECHOLAMINE RELEASE: THE CHOLINERGIC MECHANISM, Pages 280-282, Ove A. Nedergaard
EXCITATION-SECRETION COUPLING: INCREASED PROTEIN CARBOXYMETHYLATION DURING NEUROGENIC STIMULATION OF THE ADRENAL MEDULLA, Pages 283-285, O. Humberto Viveros, Emanuel J. Diliberto Jr.
CONTROL OF DOPAMINE RELEASE FROM HYPOTHALAMIC NEURONS, Pages 286-288, Francine Denizeau, Fernand Labrie
EFFECTS OF VERAPAMIL AND PRESYNAPTIC MODULATORS ON CALCIUM-INDUCED NORADRENALINE RELEASE, Pages 289-291, M. Göthert, P. Nawroth, I.-M. Pohl
MODELS OF REGULATION OF NOREPINEPHRINE SECRETION BY PREJUNCTIONAL RECEPTORS AND BY FACILITATION: ROLE OF CALCIUM AND CYCLIC NUCLEOTIDES, Pages 292-297, Lennart Stjärne, Peteris Alberts, Tomas Bartfai
EFFECTS OF β-ADRENOCEPTOR AGONISTS AND ANTAGONISTS ON NEURONAL TRANSMITTER RELEASE IN THE RAT PORTAL VEIN, Pages 298-300, Carl Dahlöf, Bengt Ljung, Bengt Åblad
STUDIES ON THE RELEASE OF PROPRANOLOL FROM ADRENERGIC NEURONS, Pages 301-303, J.G. Webb, T. Walle, H.B. Daniell, T.E. Gaffney
EVIDENCE FOR CARRIER MEDIATED EFFLUX OF NOREPINEPHRINE DISPLACED BY AMPHETAMINE, Pages 304-306, Charles O. Rutledge, Sheila Vollmer
PLASMA MEMBRANE NORADRENALINE TRANSPORT: A ROTARY LIQUID PORE MODEL, Pages 307-309, Sergio Sánchez-Armáss, Fernando Orrego
FUNCTIONAL DIFFERENTIATION WITHIN A SINGLE TYPE OF ADRENAL CHROMAFFIN CELL, Pages 310-312, S. Kobayashi, T. Hirano, N. Ozaki, T. Fujita, R.E. Coupland
SGC CELL: THE THIRD TYPE OF ADRENAL CHROMAFFIN CELL, Pages 313-315, R.E. Coupland, S. Kobayashi, Y. Serizawa, T. Fujita
ASCORBATE UPTAKE AND METABOLISM BY ADRENAL MEDULLARY CHROMAFFIN GRANULES, Pages 316-318, J.G. Tirrell, E.W. Westhead
IDENTIFICATION OF ANION TRANSPORT SITES IN CHROMAFFIN GRANULES AND THEIR INVOLVEMENT IN AN OSMOTIC MECHANISM FOR EPINEPHRINE RELEASE, Pages 319-321, Christopher J. Pazoles, Carl E. Creutz, Harvey B. Pollard
CHROMAFFIN GRANULE AS A MODEL SYSTEM FOR THE STUDY OF EXOCYTOSIS, Pages 322-324, Futoshi Izumi, Takeshi Miyashita, Takeshi Kashimoto, Akihiko Wada
STRUCTURAL CHANGES IN CHROMAFFIN GRANULE MEMBRANES DURING EXOCYTOSIS, Pages 325-327, Stephen J. Morris, Duncan H. Haynes
EVIDENCE IN SUPPORT OF A CHEMIOSMOTIC MECHANISM FOR EXOCYTOSIS FROM PLATELETS, PARATHYROID AND CHROMAFFIN CELLS, Pages 328-330, Harvey B. Pollard, Christopher J. Pazoles, Carl E. Creutz
USE OF DOPAMINE β-HYDROXYLASE IN THE STUDY OF VESICLE DYNAMICS, Pages 331-333, R.A. Rush, T.J. Millar, I.W. Chubb, L.B. Geffen
QUANTITATIVE ASPECTS OF DOPAMINE-β-HYDROXYLASE AS A MARKER FOR EXOCYTOSIS OF NOREPINEPHRINE AND EPINEPHRINE, Pages 334-336, Guldborg Serck-Hanssen, Greta Bolstad, Karen B. Helle
CHARACTERIZATION OF THE PROTEINS OF THE CHROMAFFIN GRANULE MEMBRANE, Pages 337-339, E.W. Westhead, W. Ferguson, K.L. Brayman, H.L. Gibson
IDENTIFICATION, ISOLATION AND PARTIAL CHARACTERIZATION OF TWO TYPES OF NA STORAGE VESICLES IN DOG SYMPATHETIC GANGLIA, Pages 340-342, W.P. De Pother, F.H. De Smet, E.J. Van de Velde, J. Quatacker
REGULATION OF ADENYLATE CYCLASE IN CHROMAFFIN GRANULE MEMBRANES, Pages 343-345, Oren Zinder, Harvey B. Pollard
SYNEXIN: AN ADRENAL MEDULLARY PROTEIN THAT MAY BE AN INTRACELLULAR RECEPTOR FOR Ca2+ IN THE PROCESS OF EXOCYTOSIS, Pages 346-348, Carl E. Creutz, Christopher J. Pazoles, Harvey B. Pollard
SMALL NORADRENERGIC VESICLES FROM VAS DEFERENS OF CASTRATED RATS: A COMPARISON WITH LARGE NORADRENERGIC VESICLES, Pages 349-351, Gabriel Fried, Hugo Lagercrantz, Tomas Hökfelt
FLUORESCENT PROBE STUDIES OF ISOLATED CHROMAFFIN CELL MEMBRANES, Pages 352-354, F. Schneeweiss, D.V. Naquira, K. Rosenheck, A.S. Schneider
ISOLATION OF PLASMA MEMBRANE FROM ADRENAL CHROMAFFIN CELLS, Pages 355-357, D.J. Green, E.W. Westhead
ACTIN AND MYOSIN IN CHROMAFFIN CELLS: CHARACTERIZATION AND ROLES IN CELL FUNCTION, Pages 358-360, J.M. Trifaró, R. Lee
CATECHOL-BINDING PROTEIN IN RAT LIVER: SOLUBILIZATION AND SOME PROPERTIES, Pages 361-363, J.H. TONG, A. D'IORIO
UPTAKE, METABOLISM AND RELEASE OF CATECHOLAMINES IN THE LUNG, Pages 364-366, Crystal A. Leslie, Aleksander A. Mathé, Edmund Y. Tong, Ladislav Volicer, Richard Sohn
PHOTOAFFINITY LABELING OF ADRENERGIC RECEPTORS IN NEURONAL MEMBRANES, Pages 367-369, Kim Allyn Heidenreich, Edith D. Hendley
A PHOSPHOLIPID-PROTEIN MODEL OF NEUROTRANSMITTER RECEPTOR ACTIVITY, Pages 370-372, Robert O. Friedel
HYDROXYLATED METABOLITES OF TRICYCLIC ANTIDEPRESSANTS: INHIBITION OF AMINE UPTAKE AND OTHER PRE-CLINICAL STUDIES, Pages 373-375, W.Z. Potter, H.M. Calil, A. Manian, F.K. Goodwin
USE AND LIMITATIONS OF BLOOD PLATELETS AS MODELS FOR MONOAMINERGIC NEURONS, Pages 376-378, A. Pletscher, A. Saner, A. Laubscher, M. Graf
EFFECT OF ARRHYTHMOGENIC DOSES OF DESLANOSIDE ON THE UPTAKE OF MONOAMINES IN CARDIAC AND BRAIN TISSUE, AND IN PLATELETS, Pages 379-381, C.J. Helke, K.J. Kellar, R.A. Gillis
ELECTRON MICROSCOPIC LOCALIZATION OF TETRAHYDROPAPAVEROLINE IN THE RAT CAUDATE NUCLEUS, Pages 382-384, L.Y. Koda, W.T. Shier, G.F. Koob, F.E. Bloom
PRESYNAPTIC RECEPTORS AND THE REGULATION OF TRANSMITTER RELEASE IN THE PERIPHERAL AND CENTRAL NERVOUS SYSTEM: PHYSIOLOGICAL AND PHARMACOLOGICAL SIGNIFICANCE, Pages 387-398, S.Z. Langer
β-ADRENERGIC STIMULATION OF PROTEIN CARBOXYMETHYLATION AND AMYLASE SECRETION IN RAT PAROTID, Pages 399-401, Warren J. Strittmatter, Claude Gagnon, Julius Axelrod
CHANGES IN VASCULAR ADRENOCEPTOR CHARACTERISTICS BUT NOT OTHER STRUCTURAL AND FUNCTIONAL PARAMETERS CORRELATE WITH EMBRYOLOGICAL ORIGIN OF CEREBRAL BLOOD VESSELS, Pages 402-404, John A. Bevan, Rosemary D. Bevan
A REAPPRAISAL IN GUINEA-PIGS OF DRUGS PROPOSED TO BE SELECTIVE β2-ADRENOCEPTOR ANTAGONISTS, Pages 405-407, Janet C. Wanstall, Stella R. O'Donnell, Karin Walduck
INTERACTION BETWEEN β-ADRENORECEPTOR STIMULANTS AND CERTAIN PHOSPHODIESTERASE INHIBITORS ON SMOOTH MUSCLE, Pages 408-410, J. Offermeier, H.J. Griessel, F.G. van den Brink
α-ADRENERGIC RECEPTORS IN RAT AORTIC SMOOTH MUSCLE: EVIDENCE FOR TWO COOPERATIVELY INTERACTING POPULATIONS, Pages 411-413, James P. Noon, Peter J. Rice, Ross J. Baldessarini
DESENSITIZATION OF GUINEA PIG VAS DEFERENS IN RELATION TO ALPHA-ADRENORECEPTOR LIGAND BINDING, Pages 414-416, B.H. Marks, M.I. Hoick
INTERACTION OF DOPAMINE AGONISTS WITH PERIPHERAL α-ADRENOCEPTORS, Pages 417-419, Alan Gibson, Morteza Samini
ACTIONS OF CATECHOLAMINES AND COCAINE AT INHIBITORY ADRENORECEPTORS IN RAT VAS DEFERENS, Pages 420-422, Jocelyn N. Pennefather, Gwynneth M. Handberg, Stephen D. Shipley, David A. Taylor
RECEPTOR-EFFECTOR COUPLING IN CARDIAC MUSCLE, Pages 423-425, Joan Heller Brown, Steven E. Mayer
PRE-SYNAPTIC ALPHA-ADRENERGIC RECEPTORS OF CEREBRAL ARTERIES, Pages 426-428, Sue Piper Duckies
THE ESSENTIAL ROLE OF CALCIUM IN THE RESPONSE OF THE SMOOTH MUSCLE CELL MEMBRANE TO CATECHOLAMINES, Pages 429-431, Tadao Tomita, Sadaharu Usune, Edith Bülbring
CONTRIBUTION OF CYCLIC AMP IN THE DELAYED EFFECT OF NORADRENALINE ON CHRONOTROPISM OF SINOATRIAL NODE WITH SIMULTANEOUS APPLICATION OF NORADRENALINE AND ACETYLCHOLINE, Pages 432-434, Motohatsu Fujiwara, Takashi Taniguchi, Hiroyoshi Hidaka
SUBHETEROGENEITY OF β-ADRENOCEPTORS IN THE PULMONARY AND THE CARDIAC SYSTEM OF THE GUINEA PIG, Pages 435-437, J. Zaagsma, R. Oudhof, P.J.C.M. van der Heijden, J.F. Plantjé
PRESYNAPTIC AMINERGIC RECEPTORS MODULATE A RATE OF CHANGE OF TRANSMITTER RELEASE, Pages 438-440, Susan A. Newlin, Werner T. Schlapfer, Samuel H. Barondes
REGULATION OF ALPHA-ADRENERGIC RESPONSE BY ESTROGEN, Pages 441-443, J.M. Roberts, R.D. Goldfien, A. Göldfien, P.A. Insel
SELECTIVE α-AUTORECEPTOR AGONISTS, Pages 444-446, Nils-Erik Andén
STRUCTURE ACTIVITY RELATIONSHIPS OF PRE- AND POST-SYNAPTIC DOPAMINE RECEPTORS MEDIATING VASODILATION, Pages 447-449, Leon I. Goldberg, Jai D. Kohli, Jay J. Listinsky, John D. McDermed
EVIDENCE FOR CENTRAL ADRENERGIC REGULATION OF CEREBRAL VASCULAR PERMEABILITY AND BLOOD FLOW, Pages 450-452, B.K. Hartman, L.W. Swanson, M.E. Raichle, H.B. Clark, S.H. Preskorn
PHARMACOLOGICAL INFLUENCES ON PRE- AND POSTSYNAPTIC α-ADRENERGIC RECEPTORS, Pages 453-455, Wolfgang Hoefke, Ilse Streller
INHIBITION OF RENIN RELEASE BY THE SYMPATHETIC NERVOUS SYSTEM VIA α-ADRENERGIC RECEPTORS, Pages 456-458, Dieter Klaus Meyer
ARE HEART RATE AND CONTRACTILITY CONTROLLED BY DIFFERENT β-ADRENOCEPTORS?, Pages 459-461, Anders Hedberg, Enar Carlsson
RELATIONSHIP BETWEEN β-ADRENERGIC RECEPTOR AND SPECIFIC MYOCARDIAL PROTEIN SYNTHESIS, Pages 462-464, N.E. Naftchi, N.W. Tulchin, J. Heldman, R.D. Ciaranello, J. Axelrod
THE TROPHIC EFFECT OF THE SYMPATHETIC NEURON ON THE ARTERY WALL IN GROWING RABBITS, Pages 465-467, R.D. Bevan, H. Tsuru
CATECHOLAMINE RECEPTORS IN THE CENTRAL NERVOUS SYSTEM: MULTIPLE SUBTYPES, Pages 468-473, K.P. Minneman, P.B. Molinoff
THE CHEMISTRY AND PHARMACOLOGY OF CATECHOLAMINES AND OTHER LOW MOLECULAR WEIGHT LIGANDS CONJUGATED TO CARRIERS, Pages 474-476, K.L. Melmon, L. Krasny, N. Castagnoli, P. Insel, M.S. Verlander, M. Goodman, N. Kaplan
REGULATION OF β-ADRENERGIC RECEPTORS IN HUMAN ASTROCYTOMA CELLS, Pages 477-479, T.K. Harden, S.J. Foster, J.P. Perkins
TACHYPHYLAXIS TO CATECHOLAMINES IN CULTURED BHK CELLS, Pages 480-482, G.A. Robison, S.J. Strada, W.J. Thompson, I. Morishima, B. Couture-Murillo
REFRACTORINESS TO β-ADRENERGIC AGONISTS IN S49 CELLS, Pages 483-485, P.A. Insel, M. Shear, M. Sanda, K.L. Melmon, J.W. Peabody, L.M. Stoolman, M.S. Kennedy
INHIBITION OF MAGNESIUM TRANSPORT BY β-ADRENERGIC AGONISTS IS NOT MEDIATED BY CYCLIC AMP, Pages 486-488, Michael E. Maguire, Stephanie J. Bird, Joseph J. Erdos
CONTROL OF β-ADRENERGIC RECEPTORS IN HELA CELLS, Pages 489-491, John F. Tallman, Richard C. Henneberry, Fusao Hirata, Julius Axelrod
RECEPTOR-MEDIATED CYCLIC GMP FORMATION BY AN ADRENERGIC CLONE (NIE-115) OF MOUSE NEUROBLASTOMA, Pages 492-494, John E. Taylor, Elliott Richelson
CATECHOLAMINE-INDUCED DESENSITIZATION OF THE β-RECEPTOR-LINKED ADENYLATE CYCLASE, Pages 495-497, John P. Perkins, Ying-fu Su, T. Kendall Harden
BETA ADRENERGIC AND DOPAMINE (DA) RECEPTORS IN BRAIN CAPILLARIES, Pages 498-500, Gene C. Palmer
PHOSPHOLIPID METHYLATION, MEMBRANE FLUIDITY AND COUPLING OF THE β-ADRENERGIC RECEPTOR, Pages 501-504, Fusao Hirata, Warren J. Strittmatter, Julius Axelrod
THE TURKEY ERYTHROCYTE: A CATECHOLAMINE-RESPONSIVE CELL IN WHICH TO STUDY THE POSSIBLE ROLE OF PROTEIN PHOSPHORYLATION IN THE CONTROL OF CATION TRANSPORT, Pages 505-507, S.L. Alper, H.C. Palfrey, K.G. Beam, P. Greengard
3H-CATECHOLAMINE BINDING TO CNS ADRENERGIC RECEPTORS: GUANINE NUCLEOTIDE AND DIVALENT CATION INTERACTIONS, Pages 508-510, David C. U'Prichard, Solomon H. Snyder
GUANYL NUCLEOTIDES ARE ENDOGENOUS COMPONENTS OF THE BRAIN WHICH COUPLE CATECHOLAMINE RECEPTORS TO ADENYLATE CYCLASE, Pages 511-513, T.C. Chen, T.E. Cote, J.W. Kebabian
SPIROISOBENZOFURAN PIPERIDINE DERIVATIVES. INTERACTION WITH PRE- AND POST-SYNAPTIC DOPAMINERGIC SITES, Pages 514-516, S.K. Puri, C.R. Mantione, W. Petko, D.B. Ellis
PHARMACOLOGICAL CHARACTERIZATION OF THE CATECHOLAMINERGIC RECEPTORS REGULATING cAMP ACCUMULATION IN RAT STRIATUM, Pages 517-519, H.M. Sarau, J.A. Heltzel, P.E. Setler, J.J. Foley
ADRENERGIC RECEPTORS AND ADENYLATE CYCLASE IN MEMBRANE PREPARATIONS FROM THE CENTRAL NERVOUS SYSTEM, Pages 520-522, J.W. Daly, C.R. Partington
CHARACTERIZATION, ADAPTATION AND REGULATORY CHANGES OF THE NOREPINEPHRINE (NE) RECEPTOR COUPLED ADENYLATE CYCLASE SYSTEM IN LIMBIC FOREBRAIN STRUCTURES, Pages 523-525, Philip L. Mobley, Radhakant Mishra, Fridolin Sulser
IN VIVO CYCLIC NUCLEOTIDE CONTENT: EFFECTS OF DOPAMINERGIC AGONISTS AND ANTAGONISTS, Pages 526-528, G.R. Breese, R.B. Mailman, R.A. Mueller, D.B.A. Lundberg
MODULATION OF CYCLIC NUCLEOTIDE METABOLISM BY ANTIPSYCHOTICS THROUGH A NON-DOPAMINE RECEPTOR, Pages 529-531, Benjamin Weiss, Robert M. Levin, Louise H. Greenberg
CATECHOLAMINE SENSITIVE ATPases IN THE CENTRAL NERVOUS SYSTEM, Pages 532-534, I.K. Ho, D. Desaiah
CATECHOLAMINE RECEPTOR BINDING IN BRAIN, Pages 535-541, Solomon H. Snyder, David C. U'Prichard, Ian Creese
CHARACTERIZATION OF THE EFFICACY OF β-ADRENERGIC RECEPTOR AGONISTS IN TERMS OF THE STEADY STATE MODEL FOR THE ACTIVATION OF ADENYLATE CYCLASE, Pages 542-546, John P. Perkins, T. Kendall Harden, Ying-fu Su
THE BETA-ADRENERGIC RECEPTOR OF FROG ERYTHROCYTE: PURIFICATION BY BIOSPECIFIC AFFINITY CHROMATOGRAPHY, Pages 547-549, Marc G. Caron, Yogambal Srinivasan, Josef Pitha, Robert J. Lefkowitz
POSITIVE HOMOTROPIC COOPERATIVITY OF PRESYNAPTIC [3H]-DIHYDRO-ERGOCRYPTINE BINDING IN RAT HEART MEMBRANES, Pages 550-552, Pascale Guicheney, Ricardo P. Garay, Claire Levy-Marchal, Philippe Meyer
NATURE OF DOPAMINE RECEPTORS IN THE STRIATUM AND NUCLEUS ACCUMBENS, Pages 553-555, A. Hitri, W.J. Weiner, H.L. Klawans
DIFFERENT NEUROLEPTIC RECEPTORS IN VARIOUS RAT BRAIN AREAS, Pages 556-558, Josée E. Leysen
IN VITRO DESENSITIZATION OF β-ADRENERGIC RECEPTORS IN RAT CORTEX, Pages 559-561, M.D. Dibner, P.B. Molinoff
3H-SPIROPERIDOL BINDING IN THE RAT STRIATUM: EVIDENCE FOR THE PRESENCE OF TWO BINDING SITES, Pages 562-564, Michael S. Briley, Salomon Z. Langer
3H-DOMPERIDONE AND 3H-PIMOZIDE : MORE SPECIFIC LIGANDS FOR DOPAMINE RECEPTORS STUDIED IN VITRO AND IN VIVO, Pages 565-567, Michel Baudry, Marie-Pascale Martres, Jean-Charles Schwartz
ENANTIOSELECTIVITY IN THE BINDING OF (+)- AND (−)-2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE AND RELATED AGONISTS TO DOPAMINE RECEPTORS, Pages 568-570, John D. McDermed, Harold S. Freeman, Robert M. Ferris
BIOCHEMICAL EVIDENCE FOR ‘PRE-’ AND ‘POSTSYNAPTIC’ ALPHA ADRENOCEPTORS IN RAT BRAIN, Pages 571-573, Peter J. MIACH, Jean-Pierre DAUSSE, Philippe MEYER
COMPARISON OF 3H-DIHYDROALPRENOLOL BINDING TO PUTATIVE β1 AND β2-ADRENERGIC RECEPTORS SITES IN THE CNS OF SEVERAL MAMMALIAN SPECIES, Pages 574-576, Laura Sunn, David B. Bylund
DECREASED CDR RELEASE FROM STRIATAL MEMBRANES OF CHRONICALLY HALOPERIDOL TREATED RATS, Pages 577-579, Margaret E. Gnegy
REGULATION OF β-ADRENERGIC RECEPTORS IN RAT CEREBRAL CORTEX, Pages 580-582, P.B. Molinoff, B.B. Wolfe, K.P. Minneman, M.D. Dibner
CATECHOLAMINE RECEPTOR STABILIZATION: A POSSIBLE MODE OF LITHIUM'S ANTI-MANIC ACTION, Pages 583-585, Candace B. Pert, Agu Pert, Jack E. Rosenblatt, John F. Tallman, William E. Bunney Jr.
β-ADRENOCEPTOR SENSITIVITY FOLLOWING PSYCHOTROPIC DRUG TREATMENT, Pages 586-588, S.K. Chanda, V.K. Sharma, S.P. Banerjee
CENTRAL EFFECTS OF BETA-ADRENOCEPTOR ANTAGONISTS, Pages 589-591, Olle Almgren, Jörgen Engel, Jan Jonason
MESOLIMBIC NOREPINEPHRINE AND CHANGES IN BEHAVIORAL RESPONSIVENESS TO APOMORPHINE IN RATS, Pages 592-594, A.R. Cools, P.A.M. van Dongen, P. van Well
SUBSENSITIVITY OF STRIATAL DOPAMINE TARGET CELLS AFTER REPEATED TREATMENT WITH APOMORPHINE DIPIVALOYL ESTER, Pages 595-597, B. Scatton, M. Briley, P. Worms
AUTORADIOGRAPHIC LOCALIZATION OF DOPAMINE AND NEUROLEPTIC RECEPTORS IN THE RAT BRAIN USING 3H-SPIPERONE, Pages 598-600, L. Charles Murrin, Nikolai Klemm, Michael J. Kuhar
MULTIPLE DOPAMINE RECEPTORS, Pages 601-603, Ian Creese, Solomon H. Snyder
TWO POPULATIONS OF DA RECEPTORS IN RAT STRIATUM AND THEIR RELATION TO THE EFFECT OF NEUROLEPTICS ON DA METABOLISM, Pages 604-606, P.F. SPANO, S. GOVONI, E. STEFANINI, M. TRABUCCHI
CENTRAL NORADRENERGIC NEURONS: STRUCTURE-FUNCTION CONSIDERATIONS